Capsugel strives to understand the stability and scalability challenges associated with biotherapeutics and develop solutions. We use solid-state formulations as a solution for shipping intermediate or final drug products, as well as mitigating cold chain storage and applications in developing nations. The formulations we develop are suitable for clinical and commercial production in existing current Good Manufacturing Practice (cGMP) facilities.
Our offering is focused on the following areas:
Stable vaccines with long shelf lives and reduced dependency on the cold chain are ideal for stockpiling and rapid deployment during public emergencies, including pandemics. Spray drying is a low-cost process that has potential to produce vaccines stable at a wide range of temperatures.